pHAGE-PIK3CA Citations (4)
Originally described in: Systematic Functional Annotation of Somatic Mutations in Cancer.Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J, Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y, Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR, Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB Cancer Cell. 2018 Mar 12;33(3):450-462.e10. doi: 10.1016/j.ccell.2018.01.021. PubMed Journal
Articles Citing pHAGE-PIK3CA
| Articles |
|---|
| PIK3CA hotspot mutations p. H1047R and p. H1047L sensitize breast cancer cells to thymoquinone treatment by regulating the PI3K/Akt1 pathway. Zhou J, Imani S, Shasaltaneh MD, Liu S, Lu T, Fu J. Mol Biol Rep. 2022 Mar;49(3):1799-1816. doi: 10.1007/s11033-021-06990-x. Epub 2021 Nov 23. PubMed |
| ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component. Jauhiainen S, Ilmonen H, Vuola P, Rasinkangas H, Pulkkinen HH, Keranen S, Kiema M, Liikkanen JJ, Laham-Karam N, Laidinen S, Beter M, Aavik E, Lappalainen K, Lohi J, Aronniemi J, Ord T, Kaikkonen MU, Salminen P, Tukiainen E, Yla-Herttuala S, Laakkonen JP. Elife. 2023 May 18;12:e82543. doi: 10.7554/eLife.82543. PubMed |
| Vertical inhibition of p110alpha/AKT and N-cadherin enhances treatment efficacy in PIK3CA-aberrated ovarian cancer cells. Zhang S, Hong HI, Mak VCY, Zhou Y, Lu Y, Zhuang G, Cheung LWT. Mol Oncol. 2025 Apr;19(4):1132-1154. doi: 10.1002/1878-0261.13761. Epub 2024 Nov 14. PubMed |
| Dyr726, a brain-penetrant inhibitor of PI3Kalpha, Type III receptor tyrosine kinases, and WNT signaling. Tandon V, Fistrovich A, Nogales J, Ferro F, Rokey SN, Cabel C, Miller AD, Yagel M, Duncan C, Atmasidha A, Sharma I, Wilms G, Williams K, Elliott R, Chavez T, Shaw Y, McMahon A, Ginn S, Basantes LE, Bedard N, Gokhale V, Ellis N, Prescott AR, Smith SJ, Rahman R, Becker W, Read KD, Chalmers AJ, Carragher N, Masson GR, Montfort W, Thorne C, Hulme C, Banerjee S. bioRxiv [Preprint]. 2025 Mar 29:2025.03.26.645490. doi: 10.1101/2025.03.26.645490. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.